Antibiotic resistance is “one of the biggest threats to global health, food security, and development today” says The World Health Organization (WHO). It can affect anyone, of any age, in any country. It is a huge health problem today as a growing number of infections such as pneumonia, tuberculosis, and gonorrhea are becoming increasingly difficult to treat.
Given cannabidiol’s documented anti-inflammatory effects, existing safety data in humans, and potential for varied delivery routes, it is a promising new antibiotic worth further investigation. The combination of inherent antimicrobial activity and potential to reduce damage caused by the inflammatory response to infections is particularly attractive.